REGISTERED NUMBER: 04134346 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 January 2025

for

Newport Pharmacy Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

A S Mather

Ms J E Morris

SECRETARY:

A S Mather

REGISTERED OFFICE:

2 Market Street

NEWPORT

Pembrokeshire

SA42 0PH

REGISTERED NUMBER:

04134346 (England and Wales)

ACCOUNTANTS:

Ashmole & Co

Manchester House

Grosvenor Hill

Cardigan

Ceredigion

SA43 1HY

FIXED ASSETS

Intangible assets

4

100,000

200,000

Tangible assets

5

44,298

37,413

144,298

237,413

CURRENT ASSETS

Stocks

72,947

70,770

Debtors

6

383,134

383,975

Cash at bank and in hand

482,325

279,225

938,406

733,970

CREDITORS

Amounts falling due within one year

7

396,766

414,993

NET CURRENT ASSETS

541,640

318,977

TOTAL ASSETS LESS CURRENT LIABILITIES

685,938

556,390

PROVISIONS FOR LIABILITIES

8

8,417

7,108

NET ASSETS

677,521

549,282

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

677,519

549,280

SHAREHOLDERS' FUNDS

677,521

549,282

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 August 2025 and were signed on its behalf by:

A S Mather - Director

1.	STATUTORY INFORMATION

Newport Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2001, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

15% on reducing balance

Fixtures and fittings

-

15% on reducing balance

Motor vehicles

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Goodwill acquired from treboeth pharmacy

The Directors consider that the goodwill acquired from the subsidiary company on 31st January 2016 should be written off over 10 years.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 23 (2024 - 20 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 February 2024

and 31 January 2025

1,215,129

AMORTISATION

At 1 February 2024

1,015,129

Amortisation for year

100,000

At 31 January 2025

1,115,129

NET BOOK VALUE

At 31 January 2025

100,000

At 31 January 2024

200,000

5.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Motor

machinery

fittings

vehicles

Totals

£

£

£

£

COST

At 1 February 2024

8,005

168,866

11,231

188,102

Additions

-

15,251

-

15,251

At 31 January 2025

8,005

184,117

11,231

203,353

DEPRECIATION

At 1 February 2024

7,788

136,324

6,577

150,689

Charge for year

33

7,169

1,164

8,366

At 31 January 2025

7,821

143,493

7,741

159,055

NET BOOK VALUE

At 31 January 2025

184

40,624

3,490

44,298

At 31 January 2024

217

32,542

4,654

37,413

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.25

31.1.24

£

£

Trade debtors

357,877

357,739

Other debtors

25,257

26,236

383,134

383,975

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.1.25

31.1.24

£

£

Trade creditors

296,456

291,981

Amounts owed to group undertakings

30

30

Taxation and social security

93,452

53,986

Other creditors

6,828

68,996

396,766

414,993

8.	PROVISIONS FOR LIABILITIES

31.1.25

31.1.24

£

£

Deferred tax

8,417

7,108

Deferred

tax

£

Balance at 1 February 2024

7,108

Charge to Statement of Income and Retained Earnings during year

1,309

Balance at 31 January 2025

8,417